Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its flagship cancer research assay that enables comprehensive genomic profiling. Comprehensive ...

Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a ...

It is the story of Chernobyl’s feral dogs, and it begins not with a whimper but with a nuclear boom a boom that, some four decades ago, transformed a thriving village into a zone of exclusion, and ...

Since 2022, India has a scientifically proven, indigenous Lumpy Skin Disease-specific vaccine readily available but there has ...

意大利罗马Agostino Gemelli综合医院妇科肿瘤科Vanda ...